Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Beactica Therapeutics AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 757 Less Arrow 666 Less Arrow 660
Financial expenses 7 More Arrow 10 Equal arrow 10
Earnings before taxes -428 Less Arrow -813 Less Arrow -957
EBITDA -427 Less Arrow -788 Less Arrow -929
Total assets 2,801 Less Arrow 2,701 More Arrow 3,280
Current assets 465 Less Arrow 385 More Arrow 1,157
Current liabilities 206 More Arrow 213 More Arrow 388
Equity capital 2,595 Less Arrow 2,444 More Arrow 2,798
- share capital 34 Less Arrow 32 Less Arrow 30
Employees (average) 6 More Arrow 9 Less Arrow 8

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 92.6% Less Arrow 90.5% Less Arrow 85.3%
Turnover per employee 126 Less Arrow 74 More Arrow 82
Profit as a percentage of turnover -56.5% Less Arrow -122.1% Less Arrow -145.0%
Return on assets (ROA) -15.0% Less Arrow -29.7% More Arrow -28.9%
Current ratio 225.7% Less Arrow 180.8% More Arrow 298.2%
Return on equity (ROE) -16.5% Less Arrow -33.3% Less Arrow -34.2%
Change turnover 115 Less Arrow 4 More Arrow 258
Change turnover % 18% Less Arrow 1% More Arrow 64%
Chg. No. of employees -3 More Arrow 1 Less Arrow 0
Chg. No. of employees % -33% More Arrow 13% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.